Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma (RAD001)

This study has been terminated.
(delayed recruitment)
Information provided by (Responsible Party):
Heinrich-Heine University, Duesseldorf Identifier:
First received: July 3, 2009
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)